8PSD
SARS-CoV-2 XBB 1.0 closed conformation.
8PSD の概要
エントリーDOI | 10.2210/pdb8psd/pdb |
EMDBエントリー | 17850 |
分子名称 | Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose (2 entities in total) |
機能のキーワード | sars-cov2, cryoem, rbd-binding, fab, viral protein |
由来する生物種 | Severe acute respiratory syndrome coronavirus 2 |
タンパク質・核酸の鎖数 | 3 |
化学式量合計 | 408590.38 |
構造登録者 | |
主引用文献 | Fenwick, C.,Turelli, P.,Duhoo, Y.,Lau, K.,Herate, C.,Marlin, R.,Lamrayah, M.,Campos, J.,Esteves-Leuenberger, L.,Farina, A.,Raclot, C.,Genet, V.,Fiscalini, F.,Cesborn, J.,Perez, L.,Dereuddre-Bosquet, N.,Contreras, V.,Lheureux, K.,Relouzat, F.,Abdelnabi, R.,Leyssen, P.,Levy, Y.,Pojer, F.,Le Grand, R.,Trono, D.,Pantaleo, G. Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys. J Infect, 87:524-537, 2023 Cited by PubMed Abstract: Due to the rapid evolution of SARS-CoV-2 to variants with reduced sensitivity to vaccine-induced humoral immunity and the near complete loss of protective efficacy of licensed therapeutic monoclonal antibodies, we isolated a potent, broad-spectrum neutralizing antibody that could potentially provide prophylactic protection to immunocompromised patient populations. PubMed: 37852477DOI: 10.1016/j.jinf.2023.10.008 主引用文献が同じPDBエントリー |
実験手法 | ELECTRON MICROSCOPY (2.9 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード